These findings implicate that Oct3−/− mice are more susceptible for liver tumor development due to enhanced proliferation and match the results in human HCC that the downregulation of OCT expression is associated with advanced tumor stages [15]. This evidence concerns the gene SLC22A3 and hepatocellular carcinoma.